机译:Effects of dalteparin on anti‐Xa activities cannot be predicted in critically ill COVID‐19 patients
Department of Pharmacy, Radboud University Medical Center,Radboud Institute for Health Sciences;
Department of Clinical Chemistry,Radboud University Medical Center;
Department of Internal Medicine, Radboud Institute for Health Sciences,Radboud University MedicalDepartment of Intensive Care,Radboud University Medical Center;
anti‐Xa; COVID‐19; critical care; dalteparin; low‐molecular weight heparin; pharmacokinetics; therapeutic drug monitoring;